The objective of this paper is to determine if phenobarbital exposure durin
g pregnancy affects developmental outcome at age 2 years. Between 1991 and
1994, 401 pregnant patients at risk for delivery prior to 34 weeks' gestati
on were invited to participate; 48 mothers declined entry. Before delivery,
pharmacy randomized the pregnant women to receive phenobarbital and vitami
n K or identically appearing placebo in a blinded fashion. Developmental fo
llow-up at age 2 years was performed. Children from the treatment group sco
red significantly lower on the Bayley Mental Developmental Index (mean MDI
+/-: 1 SD) than children whose mothers were randomized to the placebo group
[104 +/- 21 (n = 59) vs. 113 +/- 22 (n = 62), p=0.023]. Of 36 independent
variables, randomization group was one of five that individually contribute
d to the prediction of the Bayley MDI score (p < 0.05). It was concluded th
at perinatal phenobarbital therapy may impair developmental outcome.